Mirtazapine Tablet
Product Images NDC 72162-1640

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Mirtazapine (NDC 72162-1640). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

S:\exranbaxy\san-reg\regulatory\spl\deepa\2020\mrtazapine\20191016_f23631be-c7ae-46e9-b771-a70be17bc9f0\mirtazapine-01.jpg (Mirtazapine 01)

S:\exranbaxy\san-reg\regulatory\spl\deepa\2020\mrtazapine\20191016_f23631be-c7ae-46e9-b771-a70be17bc9f0\mirtazapine-01.jpg (Mirtazapine 01)
Chemical structure diagram of mirtazapine, depicting its molecular framework including nitrogen-containing rings and a methyl group attached to a nitrogen atom.*
FDA Label Image

Label (Lbl721621640)

Label (Lbl721621640)
Label for Mirtazapine Tablets, USP 30 mg, containing 30 tablets. The label includes storage instructions, caution to keep out of reach of children, and dispensing guidance. Labeler is Bryant Ranch Prepack, Inc., with manufacturing by ALKALOIDA Chemical Company Zrt. The product NDC is 72162-1640-3.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.